These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 25840981

  • 1. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.
    Luo H, Hong H, Slater MR, Graves SA, Shi S, Yang Y, Nickles RJ, Fan F, Cai W.
    J Nucl Med; 2015 May; 56(5):758-63. PubMed ID: 25840981
    [Abstract] [Full Text] [Related]

  • 2. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
    Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W.
    J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778
    [Abstract] [Full Text] [Related]

  • 3. 89Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection.
    Price EW, Carnazza KE, Carlin SD, Cho A, Edwards KJ, Sevak KK, Glaser JM, de Stanchina E, Janjigian YY, Lewis JS.
    J Nucl Med; 2017 Sep; 58(9):1386-1394. PubMed ID: 28280216
    [Abstract] [Full Text] [Related]

  • 4. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
    Su X, Cheng K, Liu Y, Hu X, Meng S, Cheng Z.
    Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877
    [Abstract] [Full Text] [Related]

  • 5. Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model.
    Kim KI, Jang SJ, Park JH, Lee YJ, Lee TS, Woo KS, Park H, Choe JG, An GI, Kang JH.
    J Nucl Med; 2014 Oct; 55(10):1692-8. PubMed ID: 25091475
    [Abstract] [Full Text] [Related]

  • 6. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH, Jeppesen TE, Kristensen LK, Jensen MM, El Ali HH, Madsen J, Wiinberg B, Petersen LC, Kjaer A.
    J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
    [Abstract] [Full Text] [Related]

  • 7. 64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents.
    Kwon LY, Scollard DA, Reilly RM.
    Mol Pharm; 2017 Feb 06; 14(2):492-501. PubMed ID: 28049295
    [Abstract] [Full Text] [Related]

  • 8. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ, Cao PJ, Hedley DW, Sidhu SS, Winnik MA, Reilly RM.
    Nucl Med Biol; 2015 Feb 06; 42(2):71-7. PubMed ID: 25456837
    [Abstract] [Full Text] [Related]

  • 9. Immuno-PET of tissue factor in pancreatic cancer.
    Hong H, Zhang Y, Nayak TR, Engle JW, Wong HC, Liu B, Barnhart TE, Cai W.
    J Nucl Med; 2012 Nov 06; 53(11):1748-54. PubMed ID: 22988057
    [Abstract] [Full Text] [Related]

  • 10. PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.
    Shi S, Orbay H, Yang Y, Graves SA, Nayak TR, Hong H, Hernandez R, Luo H, Goel S, Theuer CP, Nickles RJ, Cai W.
    J Nucl Med; 2015 Jun 06; 56(6):927-32. PubMed ID: 25883125
    [Abstract] [Full Text] [Related]

  • 11. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
    Kumar SR, Gallazzi FA, Quinn TP, Deutscher SL.
    J Nucl Med; 2011 Nov 06; 52(11):1819-26. PubMed ID: 21984800
    [Abstract] [Full Text] [Related]

  • 12. 64Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor-Expressing Tumors.
    Pyo A, Yun M, Kim HS, Kim TY, Lee JJ, Kim JY, Lee S, Kwon SY, Bom HS, Kim HS, Kim DY, Min JJ.
    J Nucl Med; 2018 Feb 06; 59(2):340-346. PubMed ID: 28916621
    [Abstract] [Full Text] [Related]

  • 13. PET of vascular endothelial growth factor receptor expression.
    Cai W, Chen K, Mohamedali KA, Cao Q, Gambhir SS, Rosenblum MG, Chen X.
    J Nucl Med; 2006 Dec 06; 47(12):2048-56. PubMed ID: 17138749
    [Abstract] [Full Text] [Related]

  • 14. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.
    J Nucl Med; 2004 Oct 06; 45(10):1776-83. PubMed ID: 15471848
    [Abstract] [Full Text] [Related]

  • 15. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J, Brandt-Larsen M, Schjoeth-Eskesen C, Myschetzky R, El-Ali HH, Madsen J, Kjaer A.
    Nucl Med Biol; 2014 Mar 06; 41(3):259-67. PubMed ID: 24417983
    [Abstract] [Full Text] [Related]

  • 16. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, Lee DS, Chung JK, Lee MC.
    J Nucl Med; 2008 May 06; 49(5):830-6. PubMed ID: 18413379
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
    Xavier C, Vaneycken I, D'huyvetter M, Heemskerk J, Keyaerts M, Vincke C, Devoogdt N, Muyldermans S, Lahoutte T, Caveliers V.
    J Nucl Med; 2013 May 06; 54(5):776-84. PubMed ID: 23487015
    [Abstract] [Full Text] [Related]

  • 18. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
    England CG, Jiang D, Hernandez R, Sun H, Valdovinos HF, Ehlerding EB, Engle JW, Yang Y, Huang P, Cai W.
    Mol Pharm; 2017 Oct 02; 14(10):3239-3247. PubMed ID: 28825843
    [Abstract] [Full Text] [Related]

  • 19. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.
    Hong H, Yan Y, Shi S, Graves SA, Krasteva LK, Nickles RJ, Yang M, Cai W.
    Mol Pharm; 2015 Feb 02; 12(2):403-10. PubMed ID: 25581441
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
    Cai W, Wu Y, Chen K, Cao Q, Tice DA, Chen X.
    Cancer Res; 2006 Oct 01; 66(19):9673-81. PubMed ID: 17018625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.